A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. [electronic resource]
Producer: 19940718Description: 731-4 p. digitalISSN:- 0250-7005
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Endometrial Neoplasms -- drug therapy
- Female
- Fever -- prevention & control
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Head and Neck Neoplasms -- drug therapy
- Humans
- Incidence
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mycoses -- epidemiology
- Neoplasms -- drug therapy
- Neutropenia -- epidemiology
- Ovarian Neoplasms -- drug therapy
- Prospective Studies
- Stomach Neoplasms -- drug therapy
- Thymopentin -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.